Free Trial
Tada emoji MarketBeat All Access — Now Just $5.00 for 5 Weeks

RenaissanceRe (RNR) Financials

RenaissanceRe logo
$239.94 -0.49 (-0.20%)
Closing price 03:59 PM Eastern
Extended Trading
$239.67 -0.28 (-0.12%)
As of 04:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for RenaissanceRe

Annual Income Statements for RenaissanceRe

This table shows RenaissanceRe's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders		 409 481 -245 197 712 731 -73 -1,097 2,526 1,835
Consolidated Net Income / (Loss)		 542 630 -355 269 950 993 -103 -1,160 3,620 2,961
Net Income / (Loss) Continuing Operations		 542 630 -355 269 536 993 -103 -1,160 3,620 2,961
Total Pre-Tax Income 		496 630 -328 263 553 996 -114 -1,219 3,110 2,993
Total Revenue		 1,479 1,686 2,059 2,028 3,729 5,122 5,230 5,012 9,061 11,601
Net Interest Income / (Expense)		 -36 -42 -44 -47 -58 -50 -48 -48 -73 -94
Total Interest Income		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Interest Expense		 36 42 44 47 58 50 48 48 73 94
Long-Term Debt Interest Expense		 36 42 44 47 58 50 48 48 73 94
Total Non-Interest Income		 1,515 1,728 2,104 2,075 3,788 5,172 5,278 5,060 9,135 11,695
Other Service Charges		 13 14 9.42 5.97 4.95 0.21 11 13 -6.15 1.93
Net Realized & Unrealized Capital Gains on Investments		 101 310 377 93 444 1,220 73 -1,286 1,670 1,597
Premiums Earned		 1,401 1,403 1,718 1,976 3,338 3,952 5,194 6,334 7,471 10,096
Total Non-Interest Expense		 982 1,055 2,388 1,765 3,176 4,126 5,344 6,231 5,951 8,608
Property & Liability Insurance Claims		 448 531 1,861 1,120 2,097 2,925 3,876 4,339 3,574 5,333
Other Operating Expenses		 296 235 19 34 94 97 41 47 128 135
Amortization Expense		 239 289 347 433 762 898 1,215 1,569 1,875 2,644
Other Special Charges		 - - 161 178 223 207 212 277 375 497
Income Tax Expense		 -46 0.34 26 -6.30 17 2.86 -11 -59 -510 33
Preferred Stock Dividends Declared		 22 22 22 30 37 31 33 35 35 35
Net Income / (Loss) Attributable to Noncontrolling Interest		 111 127 -132 42 201 231 -63 -99 1,059 1,090
Basic Earnings per Share		 $9.36 $11.50 ($6.15) $4.91 $16.32 $15.34 ($1.57) ($25.50) $52.40 $35.31
Weighted Average Basic Shares Outstanding		 43.16M 41.31M 39.85M 39.73M 44.15M 50.71M 43.98M 43.72M 52.69M 49.25M
Diluted Earnings per Share		 $9.28 $11.43 ($6.15) $4.91 $16.29 $15.31 ($1.57) ($25.50) $52.27 $35.21
Weighted Average Diluted Shares Outstanding		 43.16M 41.31M 39.85M 39.73M 44.15M 50.71M 43.98M 43.72M 52.69M 49.25M
Weighted Average Basic & Diluted Shares Outstanding		 43.16M 41.31M 39.85M 39.73M 44.15M 50.71M 43.98M 43.72M 52.69M 49.25M
Cash Dividends to Common per Share		 $1.20 $1.24 $1.28 - - - - - - $1.56

Quarterly Income Statements for RenaissanceRe

This table shows RenaissanceRe's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 -825 448 564 191 194 1,577 365 495 1,174 -199 161
Consolidated Net Income / (Loss)		 -1,189 693 840 375 417 1,989 618 729 1,633 -19 -25
Net Income / (Loss) Continuing Operations		 -1,189 693 840 375 417 1,989 618 729 1,633 -19 -25
Total Pre-Tax Income 		-1,186 699 869 381 426 1,434 634 708 1,735 -83 -71
Total Revenue		 1,274 2,018 2,193 1,853 1,836 3,179 2,576 2,829 3,974 2,223 3,443
Net Interest Income / (Expense)		 -12 -12 -12 0.00 0.00 -61 -23 0.00 0.00 -71 -27
Total Interest Income		 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Total Interest Expense		 12 12 12 0.00 0.00 61 23 0.00 0.00 71 27
Long-Term Debt Interest Expense		 12 12 12 - - - 23 - - - 27
Total Non-Interest Income		 1,287 2,031 2,205 1,853 1,836 3,240 2,599 2,829 3,974 2,293 3,470
Other Service Charges		 2.83 7.69 -4.31 3.88 -5.87 0.14 -0.05 0.17 0.68 1.13 0.91
Net Realized & Unrealized Capital Gains on Investments		 -483 399 529 64 86 991 156 287 1,390 -235 749
Premiums Earned		 1,767 1,624 1,681 1,785 1,756 2,249 2,444 2,541 2,583 2,528 2,721
Total Non-Interest Expense		 2,461 1,319 1,324 1,473 1,410 1,745 1,942 2,121 2,239 2,306 3,514
Property & Liability Insurance Claims		 1,968 823 801 931 862 980 1,166 1,310 1,374 1,484 2,744
Other Operating Expenses		 10 12 13 38 40 36 39 59 50 -13 23
Amortization Expense		 418 413 432 423 426 594 631 644 690 678 647
Other Special Charges		 65 72 77 80 83 134 106 108 125 157 100
Income Tax Expense		 2.81 5.41 29 5.94 9.30 -554 15 -21 102 -64 -46
Preferred Stock Dividends Declared		 8.84 8.84 8.84 8.84 8.84 8.84 8.84 8.84 8.84 8.84 8.84
Net Income / (Loss) Attributable to Noncontrolling Interest		 -372 236 267 175 214 403 245 225 450 170 -195
Basic Earnings per Share		 ($19.27) $10.40 $12.95 $4.10 $3.81 $31.54 $6.96 $9.44 $22.68 ($3.77) $3.29
Weighted Average Basic Shares Outstanding		 43.70M 43.72M 43.93M 51.18M 51.17M 52.69M 52.88M 52.16M 51.94M 49.25M 48.65M
Diluted Earnings per Share		 ($19.27) $10.40 $12.91 $4.09 $3.80 $31.47 $6.94 $9.41 $22.62 ($3.76) $3.27
Weighted Average Diluted Shares Outstanding		 43.70M 43.72M 43.93M 51.18M 51.17M 52.69M 52.88M 52.16M 51.94M 49.25M 48.65M
Weighted Average Basic & Diluted Shares Outstanding		 43.70M 43.72M 43.93M 51.18M 51.17M 52.69M 52.88M 52.16M 51.94M 49.25M 48.65M
Cash Dividends to Common per Share		 $0.37 - $0.38 $0.38 - - - - $0.39 - $0.40

Annual Cash Flow Statements for RenaissanceRe

This table details how cash moves in and out of RenaissanceRe's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Change in Cash & Equivalents		 -19 -86 940 -254 271 358 122 -665 683 -201
Net Cash From Operating Activities		 425 485 1,026 1,222 2,137 1,993 1,235 1,604 1,912 4,165
Net Cash From Continuing Operating Activities		 512 322 1,026 1,222 2,137 1,993 1,235 1,604 1,912 4,165
Net Income / (Loss) Continuing Operations		 542 630 -355 269 950 993 -103 -1,160 3,620 2,961
Consolidated Net Income / (Loss)		 542 630 -355 269 950 993 -103 -1,160 3,620 2,961
Depreciation Expense		 18 29 31 0.12 -59 17 -21 -27 -135 258
Non-Cash Adjustments to Reconcile Net Income		 73 -147 -154 230 -415 -789 219 1,646 -490 -20
Changes in Operating Assets and Liabilities, net		 -208 -27 1,503 723 1,661 1,772 1,140 1,145 -1,083 966
Net Cash From Investing Activities		 -339 -165 -122 -2,537 -2,989 -2,305 -816 -3,016 -3,823 -3,061
Net Cash From Continuing Investing Activities		 -339 -165 -122 -2,537 -2,989 -2,305 -816 -3,016 -3,823 -3,061
Purchase of Investment Securities		 -10,519 -8,470 -10,113 -14,147 -20,306 -17,638 -16,575 -52,789 -67,833 -59,478
Sale and/or Maturity of Investments		 10,180 8,121 9,875 11,611 17,325 15,196 15,552 49,773 64,011 56,417
Net Cash From Financing Activities		 -94 -401 29 1,066 1,120 665 -302 725 2,589 -1,288
Net Cash From Continuing Financing Activities		 -94 -401 29 1,066 1,120 665 -302 725 2,589 -1,288
Issuance of Debt		 446 0.00 296 0.00 396 0.00 30 0.00 816 75
Issuance of Common Equity		 - 0.00 0.00 250 0.00 1,096 0.00 0.00 1,352 0.00
Repayment of Debt		 - 0.00 -250 0.00 0.00 -250 0.00 0.00 -30 -150
Repurchase of Common Equity		 -260 -309 -189 0.00 0.00 -63 -1,028 -167 0.00 -667
Payment of Dividends		 -76 -74 -74 -83 -96 -99 -101 -100 -110 -116
Other Financing Activities, Net		 -203 -18 245 658 820 107 582 992 562 -429
Effect of Exchange Rate Changes		 -11 -4.64 8.22 -5.10 2.48 4.49 6.15 22 5.54 -17
Cash Interest Paid		 41 54 44 46 53 49 21 46 74 88
Cash Income Taxes Paid		 10 -1.12 0.34 0.34 9.75 5.67 -4.26 3.13 27 100

Quarterly Cash Flow Statements for RenaissanceRe

This table details how cash moves in and out of RenaissanceRe's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025
Net Change in Cash & Equivalents		 -194 -9.90 -131 -120 252 682 -271 20 -54 104 -44
Net Cash From Operating Activities		 601 733 436 191 772 512 683 1,212 1,490 779 158
Net Cash From Continuing Operating Activities		 601 733 436 191 772 512 683 1,212 1,490 779 158
Net Income / (Loss) Continuing Operations		 -1,189 693 840 375 417 1,989 618 729 1,633 -19 -25
Consolidated Net Income / (Loss)		 -1,189 693 840 375 417 1,989 618 729 1,633 -19 -25
Depreciation Expense		 -11 -26 -33 -40 -48 -14 16 9.96 226 6.85 3.74
Non-Cash Adjustments to Reconcile Net Income		 589 -178 -262 155 253 -637 165 139 -843 519 -190
Changes in Operating Assets and Liabilities, net		 1,212 243 -110 -299 150 -825 -116 335 475 272 369
Net Cash From Investing Activities		 -826 -1,234 -685 -2,497 -328 -314 -304 -979 -1,497 -280 -499
Net Cash From Continuing Investing Activities		 -826 -1,234 -685 -2,497 -328 -314 -304 -979 -1,497 -280 -499
Purchase of Investment Securities		 -8,749 -32,839 -12,631 -16,920 -15,850 -22,432 -14,909 -18,292 -13,906 -12,370 -14,228
Sale and/or Maturity of Investments		 7,973 31,267 11,947 14,424 15,522 22,118 14,605 17,313 12,410 12,090 13,729
Net Cash From Financing Activities		 19 500 116 2,186 -198 485 -645 -209 -58 -376 290
Net Cash From Continuing Financing Activities		 19 500 116 2,186 -198 485 -645 -209 -58 -376 290
Issuance of Debt		 - - - - -1.02 75 - - - - 866
Repayment of Debt		 - - -30 - - - -75 - -25 -50 0.00
Repurchase of Common Equity		 -25 - - - - - - - -107 -452 -358
Payment of Dividends		 -25 -25 -26 -28 -28 -29 -29 -29 -29 -29 -28
Other Financing Activities, Net		 69 525 172 119 -168 438 -540 -146 103 154 -190
Effect of Exchange Rate Changes		 13 -9.31 2.07 0.32 5.01 -1.86 -5.21 -3.57 10 -19 7.50

Annual Balance Sheets for RenaissanceRe

This table presents RenaissanceRe's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Total Assets		 11,555 12,352 15,226 18,676 26,330 30,821 33,960 36,553 49,007 50,708
Cash and Due from Banks		 507 421 1,362 1,108 1,379 1,737 1,859 1,194 1,878 1,677
Trading Account Securities		 7,309 7,399 7,917 9,299 12,803 15,564 16,144 17,551 24,612 28,108
Loans and Leases, Net of Allowance		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accrued Investment Income		 40 38 42 51 72 67 56 122 206 238
Unearned Premiums Asset		 1,009 1,429 1,838 2,153 6,159 6,644 8,905 10,872 13,550 8,179
Deferred Acquisition Cost		 199 335 427 477 664 634 849 1,172 1,751 1,552
Intangible Assets		 265 251 243 237 262 250 243 238 775 704
Other Assets		 2,226 2,479 3,398 5,350 4,991 5,925 5,903 5,405 6,235 10,250
Total Liabilities & Shareholders' Equity		 11,555 12,352 15,226 18,676 26,330 30,821 33,960 36,553 49,007 50,708
Total Liabilities		 5,777 6,310 9,538 11,579 17,287 19,872 23,781 26,692 33,451 33,156
Short-Term Debt		 391 306 209 380 225 1,133 1,171 494 662 151
Long-Term Debt		 960 949 990 991 1,384 1,136 1,168 1,170 1,959 1,887
Claims and Claim Expense		 2,767 2,848 5,080 6,076 9,384 10,381 13,295 15,893 20,487 21,303
Unearned Premiums Liability		 889 1,232 1,478 1,716 2,531 2,764 3,531 4,559 6,136 5,950
Other Long-Term Liabilities		 769 976 1,782 2,416 3,763 4,458 4,616 4,576 4,208 3,864
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest		 1,046 1,176 1,297 2,052 3,071 3,388 3,554 4,535 6,101 6,978
Total Equity & Noncontrolling Interests		 4,732 4,867 4,391 5,045 5,971 7,560 6,624 5,325 9,455 10,574
Total Preferred & Common Equity		 4,732 4,867 4,391 5,045 5,971 7,560 6,624 5,325 9,455 10,574
Preferred Stock		 400 400 400 650 650 525 750 750 750 750
Total Common Equity		 4,332 4,467 3,991 4,395 5,321 7,035 5,874 4,575 8,705 9,824
Common Stock		 551 258 77 338 612 1,674 653 519 2,197 1,563
Retained Earnings		 3,779 4,208 3,914 4,058 4,711 5,374 5,233 4,071 6,522 8,276
Accumulated Other Comprehensive Income / (Loss)		 2.11 1.13 0.22 -1.43 -1.94 -13 -11 -15 -14 -15

Quarterly Balance Sheets for RenaissanceRe

This table presents RenaissanceRe's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025
Period end date 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025
Total Assets		 35,936 38,270 41,400 40,843 50,944 51,568 52,756 53,633
Cash and Due from Banks		 1,204 1,064 944 1,196 1,607 1,627 1,573 1,633
Trading Account Securities		 15,957 18,032 19,070 19,352 24,877 26,168 28,731 28,539
Loans and Leases, Net of Allowance		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accrued Investment Income		 85 122 148 154 197 226 223 217
Unearned Premiums Asset		 11,682 11,771 12,367 6,958 9,714 15,081 9,424 14,230
Deferred Acquisition Cost		 1,181 1,242 1,301 1,267 1,822 1,816 1,719 1,685
Intangible Assets		 239 237 235 234 759 737 717 686
Other Assets		 5,587 5,802 7,242 11,683 11,968 5,913 10,369 6,644
Total Liabilities & Shareholders' Equity		 35,936 38,270 41,400 40,843 50,944 51,568 52,756 53,633
Total Liabilities		 26,879 27,047 28,321 27,592 34,854 35,053 34,653 36,595
Short-Term Debt		 590 389 548 812 1,428 778 607 552
Long-Term Debt		 1,170 1,141 1,882 1,883 1,884 1,960 1,936 2,754
Claims and Claim Expense		 15,663 15,997 16,138 15,955 20,370 20,741 21,221 22,857
Unearned Premiums Liability		 5,046 5,251 5,717 5,222 7,248 7,697 7,041 6,999
Other Long-Term Liabilities		 4,410 4,270 4,035 3,720 3,924 3,877 3,848 3,433
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest		 4,175 5,357 5,676 5,662 6,298 6,335 6,861 6,690
Total Equity & Noncontrolling Interests		 4,882 5,866 7,403 7,589 9,793 10,179 11,243 10,349
Total Preferred & Common Equity		 4,882 5,866 7,403 7,589 9,793 10,179 11,243 10,349
Preferred Stock		 750 750 750 750 750 750 750 750
Total Common Equity		 4,132 5,116 6,653 6,839 9,043 9,429 10,493 9,599
Common Stock		 509 512 1,876 1,888 2,190 2,101 2,011 1,196
Retained Earnings		 3,639 4,619 4,790 4,965 6,866 7,341 8,495 8,418
Accumulated Other Comprehensive Income / (Loss)		 -17 -15 -14 -15 -14 -13 -13 -15

Annual Metrics And Ratios for RenaissanceRe

This table displays calculated financial ratios and metrics derived from RenaissanceRe's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Growth Metrics		 - - - - - - - - - -
Revenue Growth		 19.00% 13.99% 22.17% -1.54% 83.91% 37.33% 2.11% -4.17% 80.79% 28.03%
EBITDA Growth		 -29.96% 28.21% -145.01% 188.48% 88.18% 104.80% -113.34% -822.14% 338.83% 9.29%
EBIT Growth		 -27.73% 27.00% -152.06% 180.02% 110.72% 79.97% -111.46% -968.14% 355.17% -3.76%
NOPAT Growth		 -20.99% 16.19% -136.46% 217.06% 99.38% 85.22% -108.04% -968.14% 524.31% -18.22%
Net Income Growth		 -20.99% 16.19% -156.29% 175.82% 253.37% 4.50% -110.42% -1,021.25% 412.13% -18.22%
EPS Growth		 -26.35% 23.17% -153.81% 179.84% 231.77% -6.02% -110.25% -1,524.20% 304.98% -32.64%
Operating Cash Flow Growth		 -35.67% 14.07% 111.60% 19.10% 74.94% -6.76% -38.03% 29.87% 19.20% 117.87%
Free Cash Flow Firm Growth		 -266.55% 140.74% -61.04% -827.20% -25.48% 4.58% 139.45% -77.56% -2,277.64% 151.05%
Invested Capital Growth		 30.83% 2.34% -5.62% 22.97% 25.79% 24.08% -5.30% -7.93% 57.71% 7.77%
Revenue Q/Q Growth		 3.68% -1.37% 7.08% 2.88% 3.88% 32.96% -14.81% 24.36% 14.70% -7.62%
EBITDA Q/Q Growth		 -14.86% -7.59% -14.87% -45.54% -33.16% 738.63% -120.15% 36.51% 33.56% -31.52%
EBIT Q/Q Growth		 -14.86% -7.45% -13.93% -40.16% -30.63% 897.34% -117.08% 37.70% 30.98% -33.64%
NOPAT Q/Q Growth		 -14.87% -5.21% -13.93% -31.94% -31.78% 1,235.78% -111.29% 37.70% 55.71% -40.41%
Net Income Q/Q Growth		 -14.87% -5.21% -33.53% -31.94% 20.91% 17.97% 48.30% 25.88% 55.71% -40.41%
EPS Q/Q Growth		 -21.22% -1.64% -34.87% -31.14% 20.67% 23.87% 40.53% 18.27% 67.53% -50.01%
Operating Cash Flow Q/Q Growth		 -1.03% -24.63% 45.27% -6.93% 33.77% -9.53% -15.70% 23.04% -10.35% 6.83%
Free Cash Flow Firm Q/Q Growth		 12.05% -22.01% -49.37% -70.93% 18.26% 44.46% -71.22% 213.84% -8.11% 478.48%
Invested Capital Q/Q Growth		 -2.21% -0.89% 1.22% 6.29% -1.08% -2.18% 3.76% 6.55% 13.99% -5.12%
Profitability Metrics		 - - - - - - - - - -
EBITDA Margin		 34.79% 39.13% -14.42% 12.96% 13.26% 19.77% -2.58% -24.86% 32.83% 28.03%
EBIT Margin		 33.57% 37.40% -15.94% 12.95% 14.84% 19.44% -2.18% -24.32% 34.32% 25.80%
Profit (Net Income) Margin		 36.67% 37.38% -17.22% 13.26% 25.48% 19.39% -1.98% -23.14% 39.95% 25.52%
Tax Burden Percent		 109.24% 99.95% 108.07% 102.40% 171.72% 99.71% 90.65% 95.16% 116.40% 98.91%
Interest Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate		 -9.24% 0.05% 0.00% -2.40% 3.11% 0.29% 0.00% 0.00% -16.40% 1.09%
Return on Invested Capital (ROIC)		 8.62% 8.73% -3.24% 3.50% 5.61% 8.32% -0.62% -7.10% 24.38% 15.68%
ROIC Less NNEP Spread (ROIC-NNEP)		 8.62% 8.73% -13.43% 3.50% 33.39% 8.32% -1.64% -22.42% 24.38% 15.68%
Return on Net Nonoperating Assets (RNNOA)		 1.44% 1.93% -2.81% 0.70% 6.17% 1.61% -0.36% -4.48% 4.11% 2.21%
Return on Equity (ROE)		 10.06% 10.66% -6.05% 4.21% 11.78% 9.93% -0.98% -11.58% 28.49% 17.88%
Cash Return on Invested Capital (CROIC)		 -18.09% 6.43% 2.55% -17.10% -17.23% -13.17% 4.82% 1.16% -20.41% 8.19%
Operating Return on Assets (OROA)		 5.02% 5.27% -2.38% 1.55% 2.46% 3.49% -0.35% -3.46% 7.27% 6.00%
Return on Assets (ROA)		 5.49% 5.27% -2.57% 1.59% 4.22% 3.48% -0.32% -3.29% 8.46% 5.94%
Return on Common Equity (ROCE)		 7.28% 7.94% -4.36% 2.76% 7.09% 6.14% -0.60% -6.04% 14.88% 10.01%
Return on Equity Simple (ROE_SIMPLE)		 11.46% 12.95% -8.08% 5.33% 15.91% 13.14% -1.56% -21.78% 38.29% 28.00%
Net Operating Profit after Tax (NOPAT)		 542 630 -230 269 536 993 -80 -853 3,620 2,961
NOPAT Margin		 36.67% 37.38% -11.15% 13.26% 14.38% 19.39% -1.53% -17.02% 39.95% 25.52%
Net Nonoperating Expense Percent (NNEP)		 0.00% 0.00% 10.19% 0.00% -27.78% 0.00% 1.02% 15.32% 0.00% 0.00%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 66.43% 62.60% 115.94% 87.05% 85.16% 80.56% 102.18% 124.32% 65.68% 74.20%
Earnings before Interest and Taxes (EBIT)		 496 630 -328 263 553 996 -114 -1,219 3,110 2,993
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 515 660 -297 263 494 1,013 -135 -1,246 2,975 3,252
Valuation Ratios		 - - - - - - - - - -
Price to Book Value (P/BV)		 1.06 1.18 1.19 1.17 1.57 1.16 1.30 1.73 1.14 1.32
Price to Tangible Book Value (P/TBV)		 1.13 1.25 1.27 1.24 1.65 1.20 1.36 1.83 1.26 1.42
Price to Revenue (P/Rev)		 3.11 3.11 2.31 2.53 2.23 1.60 1.46 1.58 1.10 1.11
Price to Earnings (P/E)		 11.25 10.92 0.00 26.05 11.70 11.18 0.00 0.00 3.95 7.04
Dividend Yield		 1.14% 0.97% 1.08% 1.03% 0.72% 0.87% 0.87% 0.81% 0.78% 0.63%
Earnings Yield		 8.89% 9.15% 0.00% 3.84% 8.55% 8.95% 0.00% 0.00% 25.34% 14.20%
Enterprise Value to Invested Capital (EV/IC)		 0.97 1.05 0.91 0.96 1.15 0.95 0.99 1.19 0.97 1.07
Enterprise Value to Revenue (EV/Rev)		 4.66 4.54 3.05 4.00 3.29 2.46 2.37 2.73 1.94 1.81
Enterprise Value to EBITDA (EV/EBITDA)		 13.39 11.61 0.00 30.85 24.84 12.46 0.00 0.00 5.90 6.46
Enterprise Value to EBIT (EV/EBIT)		 13.88 12.15 0.00 30.86 22.19 12.67 0.00 0.00 5.65 7.02
Enterprise Value to NOPAT (EV/NOPAT)		 12.71 12.16 0.00 30.14 22.90 12.71 0.00 0.00 4.85 7.10
Enterprise Value to Operating Cash Flow (EV/OCF)		 16.21 15.80 6.13 6.63 5.75 6.33 10.05 8.54 9.19 5.05
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 16.52 34.81 0.00 0.00 0.00 20.02 98.38 0.00 13.58
Leverage & Solvency		 - - - - - - - - - -
Debt to Equity		 0.23 0.21 0.21 0.19 0.18 0.21 0.23 0.17 0.17 0.12
Long-Term Debt to Equity		 0.17 0.16 0.17 0.14 0.15 0.10 0.11 0.12 0.13 0.11
Financial Leverage		 0.17 0.22 0.21 0.20 0.18 0.19 0.22 0.20 0.17 0.14
Leverage Ratio		 1.83 2.02 2.35 2.65 2.79 2.86 3.07 3.52 3.37 3.01
Compound Leverage Factor		 1.83 2.02 2.35 2.65 2.79 2.86 3.07 3.52 3.37 3.01
Debt to Total Capital		 18.96% 17.19% 17.40% 16.20% 15.11% 17.17% 18.69% 14.44% 14.42% 10.40%
Short-Term Debt to Total Capital		 5.49% 4.19% 3.03% 4.49% 2.11% 8.57% 9.35% 4.28% 3.64% 0.77%
Long-Term Debt to Total Capital		 13.47% 13.00% 14.37% 11.70% 12.99% 8.60% 9.33% 10.16% 10.78% 9.63%
Preferred Equity to Total Capital		 5.61% 5.48% 5.81% 7.68% 6.10% 3.97% 5.99% 6.51% 4.13% 3.83%
Noncontrolling Interests to Total Capital		 14.67% 16.11% 18.83% 24.23% 28.83% 25.64% 28.39% 39.35% 33.57% 35.62%
Common Equity to Total Capital		 60.76% 61.21% 57.96% 51.90% 49.96% 53.23% 46.93% 39.70% 47.89% 50.15%
Debt to EBITDA		 2.63 1.90 -4.04 5.22 3.26 2.24 -17.31 -1.34 0.88 0.63
Net Debt to EBITDA		 1.64 1.26 0.55 1.00 0.47 0.53 -3.55 -0.38 0.25 0.11
Long-Term Debt to EBITDA		 1.87 1.44 -3.33 3.77 2.80 1.12 -8.65 -0.94 0.66 0.58
Debt to NOPAT		 2.49 1.99 -5.22 5.10 3.00 2.28 -29.28 -1.95 0.72 0.69
Net Debt to NOPAT		 1.56 1.32 0.71 0.98 0.43 0.54 -6.01 -0.55 0.21 0.12
Long-Term Debt to NOPAT		 1.77 1.51 -4.31 3.69 2.58 1.14 -14.63 -1.37 0.54 0.64
Noncontrolling Interest Sharing Ratio		 27.63% 25.56% 27.90% 34.40% 39.80% 38.19% 38.90% 47.85% 47.75% 44.03%
Liquidity Ratios		 - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -1,138 464 181 -1,313 -1,648 -1,572 620 139 -3,031 1,547
Operating Cash Flow to CapEx		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense		 -31.37 11.00 4.09 -27.90 -28.23 -31.16 13.05 2.88 -41.42 16.50
Operating Cash Flow to Interest Expense		 11.72 11.50 23.21 25.96 36.62 39.50 25.98 33.18 26.12 44.42
Operating Cash Flow Less CapEx to Interest Expense		 11.72 11.50 23.21 25.96 36.62 39.50 25.98 33.18 26.12 44.42
Efficiency Ratios		 - - - - - - - - - -
Asset Turnover		 0.15 0.14 0.15 0.12 0.17 0.18 0.16 0.14 0.21 0.23
Fixed Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics		 - - - - - - - - - -
Invested Capital		 7,130 7,297 6,886 8,468 10,652 13,217 12,517 11,525 18,176 19,589
Invested Capital Turnover		 0.24 0.23 0.29 0.26 0.39 0.43 0.41 0.42 0.61 0.61
Increase / (Decrease) in Invested Capital		 1,680 167 -410 1,582 2,184 2,565 -700 -992 6,651 1,413
Enterprise Value (EV)		 6,891 7,658 6,285 8,105 12,279 12,620 12,415 13,693 17,559 21,012
Market Capitalization		 4,600 5,250 4,751 5,140 8,328 8,175 7,631 7,938 9,966 12,923
Book Value per Share		 $98.80 $108.53 $99.71 $109.15 $120.52 $138.46 $127.65 $104.69 $170.11 $189.14
Tangible Book Value per Share		 $92.75 $102.43 $93.64 $103.26 $114.58 $133.55 $122.36 $99.25 $154.96 $175.59
Total Capital		 7,130 7,297 6,886 8,468 10,652 13,217 12,517 11,525 18,176 19,589
Total Debt		 1,352 1,254 1,198 1,371 1,609 2,269 2,339 1,664 2,620 2,037
Total Long-Term Debt		 960 949 990 991 1,384 1,136 1,168 1,170 1,959 1,887
Net Debt		 845 833 -163 264 230 532 480 470 743 361
Capital Expenditures (CapEx)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Nonoperating Expense (NNE)		 0.00 0.00 125 0.00 -414 0.00 24 307 0.00 0.00
Net Nonoperating Obligations (NNO)		 1,352 1,254 1,198 1,371 1,609 2,269 2,339 1,664 2,620 2,037
Total Depreciation and Amortization (D&A)		 18 29 31 0.12 -59 17 -21 -27 -135 258
Earnings Adjustments		 - - - - - - - - - -
Adjusted Basic Earnings per Share		 $9.36 $11.50 ($6.15) $4.91 $16.32 $15.34 ($1.57) ($25.50) $52.40 $35.31
Adjusted Weighted Average Basic Shares Outstanding		 43.14M 40.94M 40.02M 42.21M 44.15M 50.71M 43.98M 43.72M 52.69M 49.25M
Adjusted Diluted Earnings per Share		 $9.28 $11.43 ($6.15) $4.91 $16.29 $15.31 ($1.57) ($25.50) $52.27 $35.21
Adjusted Weighted Average Diluted Shares Outstanding		 43.14M 40.94M 40.02M 42.21M 44.15M 50.71M 43.98M 43.72M 52.69M 49.25M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 43.14M 40.94M 40.02M 42.21M 44.15M 50.71M 43.98M 43.72M 52.69M 49.25M
Normalized Net Operating Profit after Tax (NOPAT)		 347 630 -117 309 752 1,199 69 -660 2,440 3,452
Normalized NOPAT Margin		 23.50% 37.38% -5.69% 15.22% 20.16% 23.41% 1.31% -13.16% 26.92% 29.75%
Pre Tax Income Margin		 33.57% 37.40% -15.94% 12.95% 14.84% 19.44% -2.18% -24.32% 34.32% 25.80%
Debt Service Ratios		 - - - - - - - - - -
EBIT to Interest Expense		 13.69 14.96 -7.43 5.58 9.48 19.74 -2.40 -25.22 42.50 31.92
NOPAT to Interest Expense		 14.95 14.95 -5.20 5.71 9.19 19.68 -1.68 -17.65 49.47 31.57
EBIT Less CapEx to Interest Expense		 13.69 14.96 -7.43 5.58 9.48 19.74 -2.40 -25.22 42.50 31.92
NOPAT Less CapEx to Interest Expense		 14.95 14.95 -5.20 5.71 9.19 19.68 -1.68 -17.65 49.47 31.57
Payout Ratios		 - - - - - - - - - -
Dividend Payout Ratio		 14.08% 11.74% -20.79% 30.84% 10.12% 10.01% -97.37% -8.63% 3.05% 3.93%
Augmented Payout Ratio		 62.01% 60.85% -73.97% 30.84% 10.12% 16.32% -1,090.70% -23.00% 3.05% 26.45%

Quarterly Metrics And Ratios for RenaissanceRe

This table displays calculated financial ratios and metrics derived from RenaissanceRe's official financial filings.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -16.86% 94.73% 153.68% 116.73% 44.07% 57.53% 17.48% 52.63% 116.44% -30.09% 33.66%
EBITDA Growth		 -78.38% 1,656.45% 288.55% 222.30% 131.58% 111.09% -22.29% 110.83% 418.62% -105.37% -110.32%
EBIT Growth		 -79.04% 1,906.89% 300.19% 228.07% 135.90% 105.27% -27.08% 85.90% 307.37% -105.80% -111.17%
NOPAT Growth		 -79.04% 2,661.29% 376.47% 280.10% 150.17% 186.81% -26.40% 94.42% 291.97% -102.93% -108.01%
Net Income Growth		 -86.10% 140.51% 311.40% 240.50% 135.03% 186.81% -26.40% 94.42% 291.97% -100.97% -104.08%
EPS Growth		 -97.64% 121.28% 241.87% 154.32% 119.72% 202.60% -46.24% 130.07% 495.26% -111.95% -52.88%
Operating Cash Flow Growth		 28.84% 69.35% 159.00% 89.19% 28.46% -30.10% 56.86% 534.83% 92.91% 51.99% -76.92%
Free Cash Flow Firm Growth		 -57.65% 150.46% -17.59% -509.33% -1,230.49% -376.60% -2,565.38% 10.16% 34.89% 68.44% 83.57%
Invested Capital Growth		 -10.34% -7.93% 4.90% 31.67% 47.41% 57.71% 52.14% 24.14% 29.48% 7.77% 4.85%
Revenue Q/Q Growth		 49.04% 58.36% 8.66% -15.49% -0.93% 73.16% -19.55% 9.79% 40.49% -44.06% 54.92%
EBITDA Q/Q Growth		 -330.00% 156.23% 24.25% -59.29% 11.03% 275.85% -54.26% 10.44% 173.12% -103.89% 12.10%
EBIT Q/Q Growth		 -299.00% 158.91% 24.39% -56.20% 11.85% 236.84% -55.81% 11.66% 145.09% -104.79% 14.85%
NOPAT Q/Q Growth		 -299.00% 183.51% 21.20% -55.40% 11.14% 377.41% -68.90% 17.81% 124.08% -103.56% 14.85%
Net Income Q/Q Growth		 -345.73% 158.32% 21.20% -55.40% 11.14% 377.41% -68.90% 17.81% 124.08% -101.18% -31.42%
EPS Q/Q Growth		 -155.91% 153.97% 24.13% -68.32% -7.09% 728.16% -77.95% 35.59% 140.38% -116.62% 186.97%
Operating Cash Flow Q/Q Growth		 495.72% 21.93% -40.57% -56.17% 304.50% -33.65% 33.36% 77.38% 22.92% -47.73% -79.74%
Free Cash Flow Firm Q/Q Growth		 -49.16% 304.42% -85.49% -1,471.71% -40.42% 1.05% -29.35% 50.01% -1.76% 52.05% 32.66%
Invested Capital Q/Q Growth		 -8.17% 6.55% 10.66% 21.61% 2.81% 13.99% 6.75% -0.78% 7.24% -5.12% 3.85%
Profitability Metrics		 - - - - - - - - - - -
EBITDA Margin		 -93.92% 33.35% 38.13% 18.37% 20.59% 44.69% 25.22% 25.37% 49.33% -3.43% -1.95%
EBIT Margin		 -93.07% 34.62% 39.64% 20.54% 23.19% 45.12% 24.60% 25.02% 43.65% -3.74% -2.06%
Profit (Net Income) Margin		 -93.29% 34.36% 38.32% 20.22% 22.69% 62.55% 24.01% 25.76% 41.09% -0.86% -0.73%
Tax Burden Percent		 100.24% 99.23% 96.67% 98.44% 97.82% 138.64% 97.57% 102.95% 94.12% 23.12% 35.69%
Interest Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate		 0.00% 0.77% 3.33% 1.56% 2.18% -38.64% 2.43% -2.95% 5.88% 0.00% 0.00%
Return on Invested Capital (ROIC)		 -22.95% 14.32% 19.51% 10.88% 13.39% 38.17% 14.10% 15.44% 28.20% -1.61% -0.90%
ROIC Less NNEP Spread (ROIC-NNEP)		 -42.79% 14.32% 19.51% 10.88% 13.39% 38.17% 14.10% 15.44% 28.20% 0.06% -0.17%
Return on Net Nonoperating Assets (RNNOA)		 -8.03% 2.86% 3.30% 1.93% 2.67% 6.43% 2.50% 2.70% 4.71% 0.01% -0.03%
Return on Equity (ROE)		 -30.98% 17.19% 22.81% 12.81% 16.07% 44.60% 16.60% 18.14% 32.91% -1.60% -0.94%
Cash Return on Invested Capital (CROIC)		 -1.07% 1.16% -4.16% -22.07% -20.95% -20.41% -20.22% 0.05% 1.46% 8.19% 6.92%
Operating Return on Assets (OROA)		 -10.80% 4.92% 6.87% 3.94% 4.77% 9.56% 5.21% 5.61% 11.71% -0.87% -0.49%
Return on Assets (ROA)		 -10.82% 4.88% 6.65% 3.88% 4.67% 13.25% 5.08% 5.77% 11.02% -0.20% -0.17%
Return on Common Equity (ROCE)		 -16.29% 8.96% 11.22% 6.44% 7.90% 23.30% 8.61% 9.86% 18.19% -0.90% -0.53%
Return on Equity Simple (ROE_SIMPLE)		 -32.05% 0.00% 1.33% 9.72% 30.64% 0.00% 34.70% 36.86% 44.19% 0.00% 22.39%
Net Operating Profit after Tax (NOPAT)		 -830 693 840 375 417 1,989 618 729 1,633 -58 -50
NOPAT Margin		 -65.15% 34.36% 38.32% 20.22% 22.69% 62.55% 24.01% 25.76% 41.09% -2.62% -1.44%
Net Nonoperating Expense Percent (NNEP)		 19.84% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -1.67% -0.73%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 193.07% 65.38% 60.36% 79.46% 76.81% 54.88% 75.40% 74.98% 56.35% 103.74% 102.06%
Earnings before Interest and Taxes (EBIT)		 -1,186 699 869 381 426 1,434 634 708 1,735 -83 -71
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -1,197 673 836 340 378 1,421 650 718 1,960 -76 -67
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 1.47 1.73 1.70 1.22 1.47 1.14 1.33 1.25 1.35 1.32 1.23
Price to Tangible Book Value (P/TBV)		 1.56 1.83 1.78 1.27 1.52 1.26 1.45 1.36 1.45 1.42 1.33
Price to Revenue (P/Rev)		 1.50 1.58 1.37 1.11 1.27 1.10 1.27 1.13 1.13 1.11 0.95
Price to Earnings (P/E)		 0.00 0.00 0.00 21.53 7.20 3.95 5.16 4.49 3.94 7.04 7.25
Dividend Yield		 1.06% 0.81% 0.75% 0.81% 0.77% 0.78% 0.65% 0.69% 0.57% 0.63% 0.65%
Earnings Yield		 0.00% 0.00% 0.00% 4.64% 13.89% 25.34% 19.38% 22.26% 25.41% 14.20% 13.80%
Enterprise Value to Invested Capital (EV/IC)		 1.07 1.19 1.20 1.03 1.13 0.97 1.07 1.04 1.10 1.07 1.03
Enterprise Value to Revenue (EV/Rev)		 2.86 2.73 2.41 2.19 2.27 1.94 2.20 1.92 1.81 1.81 1.68
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 448.82 24.58 8.07 5.90 7.44 6.32 4.80 6.46 8.26
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 180.41 21.05 7.57 5.65 7.22 6.25 5.05 7.02 9.15
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 195.66 22.30 7.73 4.85 6.11 5.33 4.59 7.10 9.04
Enterprise Value to Operating Cash Flow (EV/OCF)		 8.85 8.54 8.15 8.18 8.43 9.19 9.61 6.29 5.85 5.05 5.75
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 98.38 0.00 0.00 0.00 0.00 0.00 2,337.74 85.19 13.58 15.22
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.19 0.17 0.14 0.19 0.20 0.17 0.21 0.17 0.14 0.12 0.19
Long-Term Debt to Equity		 0.13 0.12 0.10 0.14 0.14 0.13 0.12 0.12 0.11 0.11 0.16
Financial Leverage		 0.19 0.20 0.17 0.18 0.20 0.17 0.18 0.17 0.17 0.14 0.20
Leverage Ratio		 3.61 3.52 3.43 3.30 3.44 3.37 3.27 3.14 2.99 3.01 3.16
Compound Leverage Factor		 3.61 3.52 3.43 3.30 3.44 3.37 3.27 3.14 2.99 3.01 3.16
Debt to Total Capital		 16.27% 14.44% 12.00% 15.67% 16.90% 14.42% 17.07% 14.22% 12.31% 10.40% 16.25%
Short-Term Debt to Total Capital		 5.45% 4.28% 3.05% 3.53% 5.09% 3.64% 7.36% 4.04% 2.94% 0.77% 2.71%
Long-Term Debt to Total Capital		 10.82% 10.16% 8.95% 12.14% 11.81% 10.78% 9.71% 10.18% 9.38% 9.63% 13.54%
Preferred Equity to Total Capital		 6.93% 6.51% 5.88% 4.84% 4.70% 4.13% 3.87% 3.90% 3.63% 3.83% 3.69%
Noncontrolling Interests to Total Capital		 38.60% 39.35% 42.01% 36.60% 35.51% 33.57% 32.46% 32.91% 33.23% 35.62% 32.88%
Common Equity to Total Capital		 38.20% 39.70% 40.11% 42.90% 42.89% 47.89% 46.60% 48.97% 50.82% 50.15% 47.18%
Debt to EBITDA		 -0.90 -1.34 45.03 3.72 1.21 0.88 1.19 0.86 0.54 0.63 1.30
Net Debt to EBITDA		 -0.28 -0.38 13.73 2.28 0.67 0.25 0.61 0.35 0.20 0.11 0.66
Long-Term Debt to EBITDA		 -0.60 -0.94 33.57 2.88 0.85 0.66 0.68 0.62 0.41 0.58 1.09
Debt to NOPAT		 -1.29 -1.95 19.63 3.38 1.16 0.72 0.97 0.73 0.51 0.69 1.43
Net Debt to NOPAT		 -0.41 -0.55 5.99 2.07 0.64 0.21 0.50 0.30 0.20 0.12 0.72
Long-Term Debt to NOPAT		 -0.85 -1.37 14.64 2.62 0.81 0.54 0.55 0.52 0.39 0.64 1.19
Noncontrolling Interest Sharing Ratio		 47.41% 47.85% 50.80% 49.76% 50.82% 47.75% 48.16% 45.66% 44.72% 44.03% 43.73%
Liquidity Ratios		 - - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 417 1,686 245 -3,356 -4,712 -4,663 -6,031 -3,015 -3,068 -1,471 -991
Operating Cash Flow to CapEx		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense		 34.45 136.12 20.16 0.00 0.00 -76.38 -261.05 0.00 0.00 -20.82 -36.58
Operating Cash Flow to Interest Expense		 49.69 59.21 35.91 0.00 0.00 8.40 29.58 0.00 0.00 11.02 5.82
Operating Cash Flow Less CapEx to Interest Expense		 49.69 59.21 35.91 0.00 0.00 8.40 29.58 0.00 0.00 11.02 5.82
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.12 0.14 0.17 0.19 0.21 0.21 0.21 0.22 0.27 0.23 0.24
Fixed Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 10,817 11,525 12,753 15,509 15,945 18,176 19,403 19,253 20,646 19,589 20,344
Invested Capital Turnover		 0.35 0.42 0.51 0.54 0.59 0.61 0.59 0.60 0.69 0.61 0.63
Increase / (Decrease) in Invested Capital		 -1,247 -992 596 3,731 5,129 6,651 6,650 3,744 4,701 1,413 941
Enterprise Value (EV)		 11,535 13,693 15,253 16,048 17,972 17,559 20,759 20,016 22,788 21,012 20,933
Market Capitalization		 6,055 7,938 8,678 8,135 10,061 9,966 12,006 11,819 14,207 12,923 11,820
Book Value per Share		 $94.54 $104.69 $117.01 $151.44 $133.61 $170.11 $171.01 $178.31 $201.18 $189.14 $194.89
Tangible Book Value per Share		 $89.07 $99.25 $111.60 $146.08 $129.05 $154.96 $156.66 $164.36 $187.42 $175.59 $180.96
Total Capital		 10,817 11,525 12,753 15,509 15,945 18,176 19,403 19,253 20,646 19,589 20,344
Total Debt		 1,760 1,664 1,530 2,430 2,694 2,620 3,312 2,739 2,543 2,037 3,306
Total Long-Term Debt		 1,170 1,170 1,141 1,882 1,883 1,959 1,884 1,960 1,936 1,887 2,754
Net Debt		 556 470 467 1,486 1,499 743 1,706 1,111 970 361 1,673
Capital Expenditures (CapEx)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Nonoperating Expense (NNE)		 359 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -39 -24
Net Nonoperating Obligations (NNO)		 1,760 1,664 1,530 2,430 2,694 2,620 3,312 2,739 2,543 2,037 3,306
Total Depreciation and Amortization (D&A)		 -11 -26 -33 -40 -48 -14 16 9.96 226 6.85 3.74
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($19.27) $10.40 $12.95 $4.10 $3.81 $31.54 $6.96 $9.44 $22.68 ($3.77) $3.29
Adjusted Weighted Average Basic Shares Outstanding		 43.70M 43.72M 43.93M 51.18M 51.17M 52.69M 52.88M 52.16M 51.94M 49.25M 48.65M
Adjusted Diluted Earnings per Share		 ($19.27) $10.40 $12.91 $4.09 $3.80 $31.47 $6.94 $9.41 $22.62 ($3.76) $3.27
Adjusted Weighted Average Diluted Shares Outstanding		 43.70M 43.72M 43.93M 51.18M 51.17M 52.69M 52.88M 52.16M 51.94M 49.25M 48.65M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 43.70M 43.72M 43.93M 51.18M 51.17M 52.69M 52.88M 52.16M 51.94M 49.25M 48.65M
Normalized Net Operating Profit after Tax (NOPAT)		 -785 764 915 454 497 1,098 722 571 1,751 52 21
Normalized NOPAT Margin		 -61.60% 37.88% 41.73% 24.50% 27.10% 34.54% 28.03% 20.19% 44.05% 2.33% 0.60%
Pre Tax Income Margin		 -93.07% 34.62% 39.64% 20.54% 23.19% 45.12% 24.60% 25.02% 43.65% -3.74% -2.06%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 -98.02 56.42 71.63 0.00 0.00 23.50 27.43 0.00 0.00 -1.18 -2.61
NOPAT to Interest Expense		 -68.61 55.99 69.25 0.00 0.00 32.57 26.77 0.00 0.00 -0.82 -1.83
EBIT Less CapEx to Interest Expense		 -98.02 56.42 71.63 0.00 0.00 23.50 27.43 0.00 0.00 -1.18 -2.61
NOPAT Less CapEx to Interest Expense		 -68.61 55.99 69.25 0.00 0.00 32.57 26.77 0.00 0.00 -0.82 -1.83
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 -6.37% -8.63% 128.86% 14.39% 4.59% 3.05% 3.36% 3.08% 2.34% 3.93% 4.97%
Augmented Payout Ratio		 -37.67% -23.00% 128.86% 17.91% 4.59% 3.05% 3.36% 5.97% 6.67% 26.45% 49.20%

Key Financial Trends

RenaissanceRe Holdings Ltd. (NYSE: RNR) has shown varying financial performance over the past four years, with significant fluctuations in net income, revenue components, and capital expenditures. The latest quarterly results from Q1 2025 and prior periods provide insight into trends affecting the company.

  • The company earned strong premiums over the periods reviewed, with Q1 2025 premiums earned at approximately $2.72 billion, reflecting solid underwriting activity.
  • Net realized and unrealized capital gains on investments were substantial in Q1 2025 at around $749 million, supporting income despite some challenges.
  • Consistent payment of dividends to common shareholders, with Q1 2025 dividend per share at $0.40, demonstrating shareholder returns continuity.
  • RenaissanceRe’s total assets have grown steadily, reaching approximately $53.6 billion by Q1 2025, indicating an expansion in the company’s operational scale.
  • Net cash provided by continuing operating activities in Q1 2025 was $158 million, showing operational cash generation even in a challenging quarter.
  • The company maintains significant trading account securities, over $28 billion by Q1 2025, which serves as investment liquidity but can expose the company to market volatility.
  • Total liabilities increased from approximately $27 billion in Q1 2023 to $36.6 billion in Q1 2025, reflecting expansion but also higher obligations.
  • Long-term debt levels have fluctuated with $2.75 billion outstanding as of Q1 2025, up from $1.14 billion in Q1 2023, indicating more leverage used in recent years.
  • The company reported a net loss attributable to common shareholders of $25 million in Q1 2025 compared to profits in prior quarters, signaling near-term profitability pressure.
  • Amortization and other special charges remained high in Q1 2025, totaling almost $748 million, which weighed heavily on earnings and could reflect ongoing integration or restructuring expenses.
  • Total non-interest expenses surpassed non-interest income in Q1 2025, leading to a pre-tax loss in that quarter, suggesting operational cost control is a concern.
  • The cash flow from investing activities consistently showed large outflows due to investment purchases exceeding sales, with $14.2 billion investment purchases in Q1 2025, which may impact liquidity if not balanced with returns.
  • Net income attributable to noncontrolling interests was a large negative value in Q1 2025 ($195 million), negatively impacting consolidated earnings.

Summary: RenaissanceRe exhibits a strong revenue base driven by premiums and investment gains but faced a setback in Q1 2025 with a net loss driven by high amortization charges and non-interest expenses exceeding income. The company’s balance sheet shows growth in assets and equity, supported by healthy operating cash flow, though high leverage and significant investment outlays warrant close monitoring. Investors should watch for improvements in expense management and investment income stability in upcoming quarters to gauge a return to profitability.

08/12/25 02:56 PMAI Generated. May Contain Errors.

Frequently Asked Questions About RenaissanceRe's Financials

When does RenaissanceRe's financial year end?

According to the most recent income statement we have on file, RenaissanceRe's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has RenaissanceRe's net income changed over the last 9 years?

RenaissanceRe's net income appears to be on an upward trend, with a most recent value of $2.96 billion in 2024, rising from $542.24 million in 2015. The previous period was $3.62 billion in 2023. View RenaissanceRe's forecast to see where analysts expect RenaissanceRe to go next.

How has RenaissanceRe's revenue changed over the last 9 years?

Over the last 9 years, RenaissanceRe's total revenue changed from $1.48 billion in 2015 to $11.60 billion in 2024, a change of 684.5%.

How much debt does RenaissanceRe have?

RenaissanceRe's total liabilities were at $33.16 billion at the end of 2024, a 0.9% decrease from 2023, and a 473.9% increase since 2015.

How much cash does RenaissanceRe have?

In the past 9 years, RenaissanceRe's cash and equivalents has ranged from $421.16 million in 2016 to $1.88 billion in 2023, and is currently $1.68 billion as of their latest financial filing in 2024.

How has RenaissanceRe's book value per share changed over the last 9 years?

Over the last 9 years, RenaissanceRe's book value per share changed from 98.80 in 2015 to 189.14 in 2024, a change of 91.4%.


Related Companies

This page (NYSE:RNR) was last updated on 8/12/2025 by MarketBeat.com Staff
From Our Partners
When the levee breaks
The U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...
Porter & Company | Sponsored
Man Who Called Nvidia at $1.10 Says Buy This Now...
In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...
The Oxford Club | Sponsored
Elon Musk: “Nothing happens without this…”
Lithium has fueled the EV boom, but another resource is even more critical. Without it, over 20 million electr...
Behind the Markets | Sponsored
Turn your "dead money" into $306+ monthly (starting this month)
Turn your "dead money" into $306+ monthly (starting this month) I've been tracking a financial revolution t...
Investors Alley | Sponsored
My shocking meeting in Washington, D.C.
After a shocking discovery in D.C., Jeff Brown is revealing: President Trump’s “Project MAFA” Get a look...
Brownstone Research | Sponsored
GENIUS Act: Cancel Your Money?
A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...
Priority Gold | Sponsored
Genesis 14:13-17 [HIDDEN MEANING?]
A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...
Paradigm Press | Sponsored
Market Crash Warning: How to Protect Your Wealth Before August 12th
China tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...
American Alternative | Sponsored